2015
DOI: 10.1016/j.otsr.2015.03.007
|View full text |Cite
|
Sign up to set email alerts
|

Tokuhashi score and other prognostic factors in 260 patients with surgery for vertebral metastases

Abstract: Our cohort study supports the validity and reproducibility of the Tokuhashi score. Our finding that shorter time to metastasis diagnosis and age ≥ 70 years were also significantly associated with survival in our population invites further efforts to improve and update the Tokuhashi score.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
13
0
1

Year Published

2015
2015
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(16 citation statements)
references
References 25 publications
1
13
0
1
Order By: Relevance
“…Age, preoperative motor disorders, Frankel grade categories, KPS, type of the primary tumor, presence of internal metastasis, and number of metastases in the vertebral body were found to have a significant negative effect on OS. Eap et al [18] found increased age to be a bad prognostic factor for survival, which our results also confirm. Preoperative motor disorders were previously reported to be a bad prognostic factor for survival [19,20].…”
Section: Discussionsupporting
confidence: 88%
“…Age, preoperative motor disorders, Frankel grade categories, KPS, type of the primary tumor, presence of internal metastasis, and number of metastases in the vertebral body were found to have a significant negative effect on OS. Eap et al [18] found increased age to be a bad prognostic factor for survival, which our results also confirm. Preoperative motor disorders were previously reported to be a bad prognostic factor for survival [19,20].…”
Section: Discussionsupporting
confidence: 88%
“…Mean survival for spinal metastases is dependent on tumor histology and, depending on the study cited, may range from 51 months for myeloma to 26 months for thyroid cancer to less than 6 months for lung, stomach, esophagus, or pancreatic cancer (57,58). A number of studies (57)(58)(59)(60)(61)(62)(63) have attempted to identify prognosticators or use scoring systems to predict post-treatment survival in these patients. A systematic review and meta-analysis by Luksanapruksa et al (64) identified seventeen prognosticators of poor outcomes across 43 studies, including factors such as age >65 years old, multiple metastases (bone or visceral), ≥3 involved vertebrae, non-ambulatory status before treatment, KPS <70, male gender, and increasing time from cancer diagnosis to surgery.…”
Section: Survival and Prognostic Factorsmentioning
confidence: 99%
“…Eap at al. [26] reported the reproducibility and usefulness of the system in a 260-patient population and found a weighted Cohen k coefficient of 0.41 (95% CI, 0.33-0.50). Our results confirm the findings in the literature.…”
Section: Discussionmentioning
confidence: 99%
“…The scoring systems have their own errors and pitfalls, [7,11,25,31,32] but they are widely accepted in clinical practice. [7,11,24,26,27,[33][34][35][36] The results are shown in Table 11.…”
Section: Discussionmentioning
confidence: 99%